Björkbacka, Harry

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

Björkbacka, H., Kunjathoor, V. V., Moore, K. J., Koehn, S., Ordija, C. M., Lee, M. A., Means, T., Halmen, K., Luster, A. D., Golenbock, D. T., et al. (2004) · Nature Medicine

Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism

Cited by 634

Elevated CD14 ++ CD16 − Monocytes Predict Cardiovascular Events

Berg, K. E., Ljungcrantz, I., Andersson, L., Bryngelsson, C., Hedblad, B., Fredrikson, G. N., Nilsson, J., & Björkbacka, H. (2012) · Circulation: Cardiovascular Genetics

Atherosclerosis and Cardiovascular DiseasesAdipokines, Inflammation, and Metabolic Diseases

Cited by 257

Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide

Diczfalusy, U., Olofsson, K. E., Carlsson, A.-M., Gong, M., Golenbock, D. T., Rooyackers, O., Fläring, U., & Björkbacka, H. (2009) · Journal of Lipid Research

Cholesterol and Lipid MetabolismAtherosclerosis and Cardiovascular Diseases

Cited by 204

Associations Between Macrophage Colony‐Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First‐Time Coronary Events: A Nested Case–Control Study

Schiopu, A., Bengtsson, E., Gonçalves, I., Nilsson, J., Fredrikson, G. N., & Björkbacka, H. (2016) · Journal of the American Heart Association

Atherosclerosis and Cardiovascular DiseasesLipoproteins and Cardiovascular Health

Cited by 25